Table of Contents Author Guidelines Submit a Manuscript
ISRN Oncology
Volume 2013 (2013), Article ID 924971, 12 pages
Research Article

Gene Expression Profile Analysis of T1 and T2 Breast Cancer Reveals Different Activation Pathways

1Department of Surgery, Akershus University Hospital, 1478 Lørenskog, Norway
2Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
3Department of Radiology, School of Medicine, Stanford Center for Cancer Systems Biology, Stanford University, Stanford, CA 94305-5488, USA
4Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
5Department of Clinical Molecular Biology and Laboratory Sciences (EpiGen), Akershus University Hospital, 1478 Lørenskog, Norway
6Department of Pathology, Akershus University Hospital, 1478 Lørenskog, Norway
7Institute of Health Promotion, Akershus University Hospital, 1478 Lørenskog, Norway

Received 29 November 2012; Accepted 8 January 2013

Academic Editors: A. Abdollahi, Y. Ionov, and V. Lorusso

Copyright © 2013 Margit L. H. Riis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Table S1 shows the differently expressed genes (FDR <2% by SAM) between T1 and T2 breast cancer tumors after adjustment for lymph node status, hormone receptor status, differential grade, and breast cancer subtype.

  1. Supplementary Table